Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celso Arango

Showing results (291-300 of 570) with videos related to

Pageof 57
Sort By:
Frontiers in Psychiatry|September 10, 2021
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1Mara Parellada, Antonia San José Cáceres, Melanie Palmer, et al.
Molecular Autism|August 28, 2020
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysisSpyridon Siafis, Oğulcan Çıray, Johannes Schneider-Thoma, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 2, 2019
Sensory-to-Cognitive Systems Integration Is Associated With Clinical Severity in Autism Spectrum DisorderKenia Martínez, Magdalena Martínez-García, Luis Marcos-Vidal, et al.
Schizophrenia Research|November 28, 2012
Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophreniaElena de la Serna, Susana Andrés-Perpiñá, Olga Puig, et al.
European Child & Adolescent Psychiatry|August 12, 2014
Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine modelLaura Pina-Camacho, Juan Garcia-Prieto, Mara Parellada, et al.
Schizophrenia (Heidelberg, Germany)|November 17, 2022
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosisAleix Solanes, Gisela Mezquida, Joost Janssen, et al.
The Journal of Clinical Psychiatry|November 11, 2017
The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health RecordsJohnny M Downs, Suzannah Lechler, Harry Dean, et al.
Schizophrenia Research|April 29, 2014
Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up studyMónica Martínez-Cengotitabengoa, Juan Antonio Micó, Celso Arango, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 10, 2021
Risk and protective factors for mental disorders beyond genetics: an evidence-based atlasCelso Arango, Elena Dragioti, Marco Solmi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 27, 2024
Umbrella Review: Atlas of the Meta-Analytical Evidence of Early-Onset PsychosisGonzalo Salazar de Pablo, Victoria Rodriguez, Filippo Besana, et al.
Pageof 57

Showing results (291-300 of 570) with videos related to

Sort By:
Pageof 57
Frontiers in Psychiatry|September 10, 2021
A Phase II Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Safety, and Tolerability of Arbaclofen Administered for the Treatment of Social Function in Children and Adolescents With Autism Spectrum Disorders: Study Protocol for AIMS-2-TRIALS-CT1Mara Parellada, Antonia San José Cáceres, Melanie Palmer, et al.
Molecular Autism|August 28, 2020
Placebo response in pharmacological and dietary supplement trials of autism spectrum disorder (ASD): systematic review and meta-regression analysisSpyridon Siafis, Oğulcan Çıray, Johannes Schneider-Thoma, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|July 2, 2019
Sensory-to-Cognitive Systems Integration Is Associated With Clinical Severity in Autism Spectrum DisorderKenia Martínez, Magdalena Martínez-García, Luis Marcos-Vidal, et al.
Schizophrenia Research|November 28, 2012
Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophreniaElena de la Serna, Susana Andrés-Perpiñá, Olga Puig, et al.
European Child & Adolescent Psychiatry|August 12, 2014
Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine modelLaura Pina-Camacho, Juan Garcia-Prieto, Mara Parellada, et al.
Schizophrenia (Heidelberg, Germany)|November 17, 2022
Combining MRI and clinical data to detect high relapse risk after the first episode of psychosisAleix Solanes, Gisela Mezquida, Joost Janssen, et al.
The Journal of Clinical Psychiatry|November 11, 2017
The Association Between Comorbid Autism Spectrum Disorders and Antipsychotic Treatment Failure in Early-Onset Psychosis: A Historical Cohort Study Using Electronic Health RecordsJohnny M Downs, Suzannah Lechler, Harry Dean, et al.
Schizophrenia Research|April 29, 2014
Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up studyMónica Martínez-Cengotitabengoa, Juan Antonio Micó, Celso Arango, et al.
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|September 10, 2021
Risk and protective factors for mental disorders beyond genetics: an evidence-based atlasCelso Arango, Elena Dragioti, Marco Solmi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|January 27, 2024
Umbrella Review: Atlas of the Meta-Analytical Evidence of Early-Onset PsychosisGonzalo Salazar de Pablo, Victoria Rodriguez, Filippo Besana, et al.
Pageof 57